Sian writes about emerging start-up companies and new research from academia. She is especially interested in the pet health space, as well as the introduction of digital technology for both companion animals and livestock. She also has an interest in increasing Animal Pharm's equine coverage, as she owns horses herself.
In addition to covering animal health news and conducting interviews with worldwide companies, Sian also works on the evolving Animal Pharm Product Approvals Index.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Sian Lazell
French firm Ceva Santé Animale is constructing a new vaccine plant and R&D center in Hungary.
A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.
Brakke Consulting has selected Robert Jones to take over leadership of the firm's day-to-day operations.
South Africa's Department of Agriculture, Forestry and Fisheries (DAFF) has reported positive laboratory results for foot-and-mouth disease (FMD) in cattle in the Vhembe District of Limpopo.
Two Scottish consortiums backed by the Scottish Aquaculture Innovation Centre (SAIC) are working on health projects in Atlantic salmon valued at a combined £3.5 million ($4.5 million).
French firm Ceva Santé Animale is launching MilbeGuard (milbemycin oxime) flavored tablets in the US.